Fall 2018 Vol. 08 Issue 03
-
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating CancerT cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Gathering PerspectiveA second opinion can provide additional information to determine the best treatment course.
by Hester Hill Schnipper
-
Caregiving With Confidence
Make Your Mental Health a PriorityRecognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
-
Policy Matters
A Growing Commitment to Cancer SurvivorsThe number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
-
Moving Ahead
Cancer rehabilitation can help patients before and after treatment, but it's still not widely used.
by Cameron Walker
-
New Tactics for Bladder Cancer
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
-
Raising Their Voices
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
-
Survivor Profile
The Power of PatientsJanet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
-
Q&A
A Critical ConversationPalliative care specialist Jessica Nutik Zitter offers tips to help ensure that patients' values guide end-of-life decisions.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersA patient support expert offers guidance on how to respond to news of a friend's cancer diagnosis.
-
Get Involved
Helping Kids CopeHelp with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
-
In the Moment- Fall 2018
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff